{
    "title": "Merck sees $2.1 bln coronavirus hit to 2020 sales",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-8264899/Merck-profit-beats-coronavirus-uncertainty-weighs-forecast.html",
    "date": "2020-04-28",
    "keywords": [
        "profit",
        "coronavirus",
        "merck",
        "share",
        "vaccine",
        "inc",
        "pandemic",
        "forecast",
        "end",
        "davis",
        "business",
        "johnson",
        "demand",
        "michael",
        "tuesday",
        "drugmaker",
        "drop",
        "office",
        "outbreak",
        "toll",
        "blockbuster",
        "cancer",
        "drug",
        "outlook",
        "week",
        "spread",
        "fear",
        "impact",
        "officer",
        "robert",
        "conference",
        "call",
        "hit",
        "quarter",
        "potential",
        "recovery",
        "year",
        "abate",
        "company",
        "program",
        "view",
        "amp",
        "device",
        "month",
        "rebound",
        "levesque",
        "vice",
        "president",
        "moodys",
        "beat",
        "country",
        "refinitiv",
        "benefit",
        "health",
        "gardasil",
        "papillomavirus",
        "estimate",
        "reporting",
        "bengaluru",
        "erman",
        "maplewood",
        "anil",
        "dsilva",
        "bill",
        "berkrot"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}